ATHA
Price
$0.30
Change
+$0.01 (+3.45%)
Updated
Apr 24, 04:53 PM (EDT)
Capitalization
10.5M
14 days until earnings call
SNGX
Price
$2.15
Change
+$0.08 (+3.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
6.52M
Ad is loading...

ATHA vs SNGX

Header iconATHA vs SNGX Comparison
Open Charts ATHA vs SNGXBanner chart's image
Athira Pharma
Price$0.30
Change+$0.01 (+3.45%)
Volume$200
Capitalization10.5M
Soligenix
Price$2.15
Change+$0.08 (+3.86%)
Volume$3.98K
Capitalization6.52M
ATHA vs SNGX Comparison Chart
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. SNGX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and SNGX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ATHA: $0.28 vs. SNGX: $2.07)
Brand notoriety: ATHA and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 92% vs. SNGX: 20%
Market capitalization -- ATHA: $10.5M vs. SNGX: $6.52M
ATHA [@Biotechnology] is valued at $10.5M. SNGX’s [@Biotechnology] market capitalization is $6.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATHA and SNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 4 TA indicator(s) are bullish while SNGX’s TA Score has 5 bullish TA indicator(s).

  • ATHA’s TA Score: 4 bullish, 4 bearish.
  • SNGX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNGX is a better buy in the short-term than ATHA.

Price Growth

ATHA (@Biotechnology) experienced а +23.23% price change this week, while SNGX (@Biotechnology) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.56%.

Reported Earning Dates

ATHA is expected to report earnings on Aug 18, 2025.

SNGX is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHA($10.5M) has a higher market cap than SNGX($6.52M). SNGX YTD gains are higher at: -23.191 vs. ATHA (-51.900). SNGX has higher annual earnings (EBITDA): -8.06M vs. ATHA (-95.81M). ATHA has more cash in the bank: 51.3M vs. SNGX (9.84M). ATHA has less debt than SNGX: ATHA (1.22M) vs SNGX (2.2M). ATHA (0) and SNGX (0) have equivalent revenues.
ATHASNGXATHA / SNGX
Capitalization10.5M6.52M161%
EBITDA-95.81M-8.06M1,188%
Gain YTD-51.900-23.191224%
P/E RatioN/AN/A-
Revenue00-
Total Cash51.3M9.84M521%
Total Debt1.22M2.2M55%
FUNDAMENTALS RATINGS
SNGX: Fundamental Ratings
SNGX
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHASNGX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YALA7.530.45
+6.36%
Yalla Group Limited
OKTA98.334.00
+4.24%
Okta
AUB26.350.84
+3.29%
Atlantic Union Bankshares Corp
MNTS1.770.02
+1.14%
Momentus Inc
EVC1.88-0.04
-2.08%
Entravision Communication

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OGEN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+4.91%
OGEN - ATHA
37%
Loosely correlated
+3.74%
ALNY - ATHA
35%
Loosely correlated
+2.20%
PCVX - ATHA
33%
Poorly correlated
+5.95%
MNKD - ATHA
32%
Poorly correlated
+0.66%
SNGX - ATHA
31%
Poorly correlated
+0.24%
More

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
+0.24%
THAR - SNGX
46%
Loosely correlated
+3.03%
QURE - SNGX
37%
Loosely correlated
N/A
VRAX - SNGX
36%
Loosely correlated
+6.34%
ATHA - SNGX
31%
Poorly correlated
+4.91%
VNDA - SNGX
30%
Poorly correlated
-1.81%
More